Stonepine Capital Management »

Cellectar Biosciences shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $291k 105k 2.78

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Cellectar Biosciences

Caligan Partners
Stempoint Capital
Vanguard Capital Management
Silverarc Capital Management
Bleichroeder
Jupiter Topco
Balyasny Asset Management
Nantahala Capital Management
Empery Asset Management
Diadema Partners
Stonepine Capital Management
Persistent Asset Partners
Boothbay Fund Management
Geode Capital Management
Vanguard Fiduciary Trust

View all funds holding Cellectar Biosciences